Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

People at high risk of acute myeloid leukaemia (AML) can be identified years in advance, but there is currently no treatment ...

I don't usually talk about my cancer diagnosis. But as a physician-scientist who survived leukemia at 18 years old and now ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

Family and friends of Rachel Simon of Hazlet are staging events to find a bone marrow donor who can help her fight off ...

Research from the University of Cambridge shows that metformin, a widely used and affordable diabetes drug, could prevent a ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

The FDA previously granted breakthrough therapy designation to ziftomenib for relapsed/refractory NPM1-mutant AML.

SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...